GNOM Global X - Genomics & Biotechnology ETF
Issuer
Global X
Inception
Apr 5, 2019
AUM
$108.3M
Expense ratio
0.50%
Yield
1.05%
Asset class
Equity
Holdings
50
Last price
$61.62
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
+42.8%
2025-11-13low 41.40 · high 72.542026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| GNOM | -6.5% | +5.7% | +35.7% | +44.8% | +16.3% | -6.2% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$3K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA MODERNA INC | 13.18% |
| 2 | TWST TWIST BIOSCIENCE CORP | 5.55% |
| 3 | TXG 10X GENOMICS INC-CLASS A | 5.40% |
| 4 | GH GUARDANT HEALTH INC | 5.09% |
| 5 | ILMN ILLUMINA INC | 4.81% |
| 6 | NTRA NATERA INC | 4.53% |
| 7 | 1548.HK GENSCRIPT BIOTECH CORP | 3.87% |
| 8 | QGEN QIAGEN N.V. | 3.71% |
| 9 | VRTX VERTEX PHARMACEUTICALS INC | 3.68% |
| 10 | TECH BIO-TECHNE CORP | 3.66% |
| 11 | BMRN BIOMARIN PHARMACEUTICAL INC | 3.18% |
| 12 | PRAX PRAXIS PRECISION MEDICINES I | 3.03% |
| 13 | CDNA CAREDX INC | 2.86% |
| 14 | CRSP CRISPR THERAPEUTICS AG | 2.39% |
| 15 | BNTX BIONTECH SE-ADR | 2.38% |
| 16 | LLY ELI LILLY & CO | 2.27% |
| 17 | CAI CARIS LIFE SCIENCES INC | 2.27% |
| 18 | LEGN LEGEND BIOTECH CORP-ADR | 2.22% |
| 19 | ARWR ARROWHEAD PHARMACEUTICALS IN | 1.97% |
| 20 | GILD GILEAD SCIENCES INC | 1.88% |
| 21 | BEAM BEAM THERAPEUTICS INC | 1.85% |
| 22 | BLLN BILLIONTOONE INC CL A | 1.68% |
| 23 | VCYT VERACYTE INC | 1.50% |
| 24 | AZN.L ASTRAZENECA PLC | 1.39% |
| 25 | SRPT SAREPTA THERAPEUTICS INC | 1.28% |
| 26 | RARE ULTRAGENYX PHARMACEUTICAL IN | 1.20% |
| 27 | VIR VIR BIOTECHNOLOGY INC | 1.17% |
| 28 | DHR DANAHER CORP | 1.15% |
| 29 | WGS GENEDX HOLDINGS CORP | 1.09% |
| 30 | QURE UNIQURE NV | 1.05% |
| 31 | STOK STOKE THERAPEUTICS INC | 1.00% |
| 32 | NTLA INTELLIA THERAPEUTICS INC | 0.99% |
| 33 | BMY BRISTOL-MYERS SQUIBB CO | 0.97% |
| 34 | PSNL PERSONALIS INC | 0.84% |
| 35 | MRVI MARAVAI LIFESCIENCES HLDGS-A | 0.62% |
| 36 | PACB PACIFIC BIOSCIENCES OF CALIF | 0.43% |
| 37 | WVE WAVE LIFE SCIENCES INC | 0.41% |
| 38 | FLGT FULGENT GENETICS INC | 0.39% |
| 39 | MYGN MYRIAD GENETICS INC | 0.38% |
| 40 | A AGILENT TECHNOLOGIES INC | 0.38% |
| 41 | BRKR BRUKER CORP | 0.35% |
| 42 | PRME PRIME MEDICINE INC | 0.31% |
| 43 | MLAB MESA LABORATORIES INC | 0.30% |
| 44 | RGNX REGENXBIO INC | 0.30% |
| 45 | DGX QUEST DIAGNOSTICS INC | 0.28% |
| 46 | BNTC BENITEC BIOPHARMA INC | 0.24% |
| 47 | RCKT ROCKET PHARMACEUTICALS INC | 0.20% |
| 48 | EDIT EDITAS MEDICINE INC | 0.18% |
| 49 | LAB STANDARD BIOTOOLS INC | 0.15% |
| 50 | CRBU CARIBOU BIOSCIENCES INC | 0.04% |
| 51 | GNOM CASH | -0.01% |
Sector breakdown
Healthcare99.7%
Technology0.3%
Country breakdown
United States95.2%
Switzerland2.5%
United Kingdom1.4%
Netherlands0.9%
Distributions
| Date | Per unit |
|---|---|
| Jun 29, 2026 | $0.0579 |
| Dec 30, 2025 | $0.5912 |
| Jun 27, 2025 | $0.0331 |
| Dec 30, 2021 | $0.0280 |
| Dec 30, 2020 | $0.1296 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in GNOM in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error